These studies were designed to develop a paradigm for the detection of antidepressant-induced sexual dysfunction in female rats. Ovariectomized, Fischer rats were conditioned to nose poke to open a guillotine door to gain access to a sexually active male. To develop the procedure, we examined the acquisition and stability of the response with a 15-s fixed interval, compared rats treated with 10 μg estradiol benzoate and 500 μg progesterone with those that received only estradiol benzoate, and carried out a preliminary analysis of the effects of 5, 10, and 15 mg/kg fluoxetine. We then more fully evaluated the effects of 5 mg/kg fluoxetine. Fluoxetine reduced sexual motivation, as assessed by the number of nose pokes, the number of nose poke episodes, and the latency to approach the male. In addition, changes in the females' sexual motivation were examined before and after ejaculation during the final conditioning trials. The number of nose pokes was reduced and the latency to initiate a new nose poke episode was increased following ejaculation. The robustness of the antidepressant-induced decline in sexual motivation is in marked contrast to the findings with several other animal models for sexual dysfunction and illustrates the usefulness of the operant procedure. Behavioural Pharmacology 26:697-705
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Introduction
Depression is a worldwide problem affecting ∼ 121 million people (Warden et al., 2007) . Currently available antidepressants vary in their purported mechanism of action, but most lead to some degree of sexual dysfunction (Gregorian et al., 2002; Montgomery et al., 2002; Segraves, 2007; Schweitzer et al., 2009) . Women are two to three times more likely to develop depression (Hildebrandt et al., 2003; Gorman, 2006; Shifren et al., 2008) , and antidepressant-emergent sexual dysfunction is more severe in women than in men (Shen and Hsu, 1995; Frohlich and Meston, 2000; Clayton et al., 2007; Segraves, 2007) and is often responsible for patient noncompliance in continuing treatment (Clayton, 2002; Clayton et al., 2007; Segraves, 2007; Nurnberg et al., 2008) . However, few effective options are available for treating antidepressant-induced sexual dysfunction.
Despite the high prevalence of sexual dysfunction following antidepressant treatment, there are surprisingly few studies with animal models with which effective therapeutic interventions might be identified. In humans, female sexual behavior can be broadly grouped into low desire/arousal, orgasmic difficulties, or dyspareunia (Segraves, 2007; Shifren et al., 2008) , with low sexual desire/arousal (libido) being the most common complaint following antidepressant treatment (Clayton et al., 2007; Segraves, 2007; Shifren et al., 2008) .
Unlike humans, female rodent sexual activity is dependent on gonadal hormones (Pfaff, 1970; Sodersten, 1981; McEwen and Parsons, 1982) and includes multiple behaviors that are generally categorized as appetitive (grooming, excitement, motor activation), precopulatory (proceptivity, solicitation), and consummatory (receptivity, lordosis; Pfaus et al., 2003) . Solicitation/appetitive behaviors allow the female to obtain proximity to the male (interest/arousal). Proceptive behaviors engage the male's attention toward the female (interest/arousal). Receptive behavior includes the actual act of copulation (lordosis, genital stimulation). Defensive/resistive-/avoidance behaviors (reminiscent of aversion to sexual activity) terminate the mating sequence and/or reduce the frequency of mounts and intromissions by the male.
Selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine are associated with the greatest prevalence of sexual dysfunction in humans (Montgomery et al., 2002; Outhoff, 2010) and have been the most investigated class of drugs in animal models (Uphouse, 2014) . However, in a majority of such studies, only the consummatory response (e.g. lordosis behavior) has been examined. This is unfortunate, given the predominant complaints with regard to sexual desire/arousal in humans, which may be better considered as decrements in appetitive and precopulatory systems. Although animal models of female sexual motivation have been developed that are effective in differentiating hormonally primed from nonhormonally primed ovariectomized rats (Erskine, 1989; Pfaus et al., 1999; Clark et al., 2004) , such models have been surprisingly insensitive to the effects of antidepressants such as SSRIs (Sarkar et al., 2008; Uphouse, 2014) .
Operant approaches are typically considered to be a standard approach to measuring appetitive and motivational behaviors, but they have received little emphasis in the area of female sexual motivation (Matthews et al., 1997; Agmo, 2014) . However, Matthews et al. (1997) required female rats to perform a nose poke response to gain access to a male with which sexual activity could occur. With this approach, the authors were able to demonstrate that sexual activity was reinforcing. More recently, Cummings and Becker (2012) described a variation of this procedure for investigating female sexual motivation. In the paradigm used by Cummings and Becker (2012) , female rats were trained to make nose pokes to open a door to gain access to a sexually active male. When ovariectomized females were hormonally primed with estradiol benzoate and progesterone and tested with a fixed-interval (15 s) schedule, they exhibited more nose pokes during the 15-s interval than did ovariectomized female rats without hormonal priming. With this paradigm, the authors showed that appetitive sexual behavior, as measured by the operant nose poke, was sensitive to hormonal priming. Thus, the paradigm holds promise for investigating a broader range of manipulations that impact sexual motivation. In this preliminary report, we have developed a similar paradigm and used it to evaluate the effect of the SSRI fluoxetine. It was hypothesized that fluoxetine would reduce the females' sexual motivation to access the male, and that this would be shown by fewer nose pokes and an increasing latency to approach the male.
Methods
All procedures were performed in accordance with PHS guidelines and were approved by the IACUCs at the Texas Woman's University and the University of North Texas.
Subjects
Eighteen female Sasco Fischer rats and 18 male Sprague-Dawley rats were used in the experiments. Rats were purchased from Charles River Laboratories (Wilmington, Massachusetts, USA). Males were between 100 and 150 days of age when their conditioning was initiated. Females were ∼ 80 days of age when initiated into the study.
Apparatus
The apparatus was a 41 cm high × 55 cm wide × 30.5 cm deep operant chamber divided into two compartments (41 cm high × 22 cm wide × 30.5 cm deep or 41 cm high × 33 cm wide by 30.5 cm deep) by a guillotine door (see Fig. 1 ). The female was initially placed in the smaller compartment (female compartment) where she could make the operant response; the male was tethered in the larger compartment (male compartment). The smaller compartment was equipped with two nose poke detectors to measure operant, or goal-directed, behavior; each detector was located inside the 4-cm nose poke hole, the center of which was 5 cm above the chamber floor. The centers of the holes were spaced 10 cm apart. Infrared photoemitter-detector pairs were placed across the middle of the hole; a nose poke was defined as any break in the beam that lasted at least 30 ms. Each hole could be lit by a yellow LED located 10 cm inside the hole. Only one hole was active during the study; responses on the inactive hole were used to assess general exploratory behavior.
The smaller compartment was separated from the larger compartment by a Plexiglas guillotine door, which could be raised by a DC gear motor and custom-built pulley system; the time to raise or lower the door was ∼ 500 ms. When open, the entrance way was 8 cm wide × 10 cm high and provided access between the two compartments. A female rat introduced into the smaller compartment could open the door to gain access to the male by successful nose pokes on the active hole. A sexually active male rat was tethered in the larger compartment that served as the goal box. The default state of the door was 'closed' when the female rat was introduced to the chamber. Nose pokes that satisfied the response requirements would open the guillotine door, allowing the female to pass between compartments. The location of the female could be tracked by sets of infrared detectors located on either side of the door. Because of their tethers, male rats could not cross into the operant side of the chamber. The tether was a custom-made plastic harness that connected the male to the ceiling through a flexible 11 cm steel chain leash. Programming of experimental events and data collections were accomplished using a data acquisition card (USB-6009; National Instruments, Austin, Texas, USA) and custom software written in Labview (National Instruments).
Surgical procedures and treatments
Sasco Fischer female rats, obtained from Charles River Laboratories, were ovariectomized under AErrane anesthesia 2-4 weeks after their arrival at the facility, as previously described (White and Uphouse, 2004) . Two weeks later, the female rats were hormonally primed with 10 μg estradiol benzoate, and 48 h later with 500 μg progesterone, for training in the operant paradigm. Hormones were administered subcutaneously in a volume of 0.1 ml/rat. Fluoxetine was dissolved in deionized water and administered intraperitoneally in a volume of 1.0 ml/kg, except for the 15 mg/kg dose, which was administered in a volume of 1.5 ml/kg.
Training of females in the operant chamber
Hormonally primed, ovariectomized rats were conditioned to nose poke to open a guillotine door to gain access to a sexually active male. In the shaping process, the investigator manually opened the door when the female's investigation of the chamber led her to the vicinity of the active nose poke hole. Females rapidly learned the relationship between the door and compartment entry; the female would try to open the guillotine door by nosing and pawing, and when unsuccessful, she would direct her attention toward the areas around the door. The door was opened as she oriented toward and moved toward the nose poke hole. During successive shaping intervals, the investigator required the female to come closer and closer to the hole until she initiated the nose poke response on her own. The complete procedure for training the females involved: (a) week 1: conditioning the female to the chamber, with free access to the malethat is, the door was always raised and nose pokes produced no programmed consequence; (b) weeks 2 and 3: hand-shaping the female to make one nose poke to open the door to gain access to the male in the male's chamber; (c) weeks 4 and 5: hand-shaping the female to make an increasing number of nose pokes to gain access to the male; (d) weeks 6 and 7: introduction of a response-initiated interval during which the female's first nose poke began a 15-s delay; the first nose poke at the end of the delay opened the door to gain access to the male's compartment. One or two additional weeks of training were given if necessary, until the females made a minimum of three nose pokes per episode, but this was necessary only during the procedure development phase. Training was never more frequent than weekly and generally occurred once per week on the same day of the week. During the shaping process to produce a single nose poke response to open the door to the male, females underwent an average of 7.4 0.11 (range of 3-15) shaping trials per session. During shaping to a 15-s delay, the females averaged 6.0 0.75 episodes (range of 3-10) per session. If a female failed to open the door during the test days, she was given a maximum score of 300 s. Similarly, if the female opened the door but did not cross over to the male's chamber, she was given a score of 300 s.
The female was always free to return to the operant compartment. If the female re-entered the smaller operant compartment, the door was closed behind her, and she could reopen the door by completing the response requirement again. With the exception of the first session (which lasted 30 min), training sessions continued for 15 min. A male was always present during training and the female was paired with the same male throughout training. The entire training procedure was carried out with 10 μg estradiol benzoate and 500 μg progesterone priming.
There was no requirement that the male/female pairs copulate during training, but only that the females enter the males' chamber and interact with the male. The session was terminated when the female re-entered her chamber within 30 s of the end of the timed session. Nevertheless, females usually did receive an ejaculation during the conditioning trials. To prevent negative conditioning of the male, if the male failed to ejaculate with the experimental female by the time the session ended, the male was left in the chamber with a nonexperimental, estradiol benzoate and progesterone-primed female until ejaculation occurred. In this case, the chamber door was closed and the nonexperimental female remained in the male's chamber.
Conditioning of males
Sexually experienced males were adapted to the tethering process through the following successive stages: (a) adaptation to a collar; (b) adaptation to a leash; and (c) adaptation to being tethered in the corner of the apparatus. The collar consisted of a small plastic harness constructed from a plastic cable tie, which was placed around the male rat's neck and secured. One to two days of training (depending on the male) were required before the male easily allowed attachment of the collar. Once the male accepted the collar, he was allowed to mate, collared but not tethered, with a nonexperimental, receptive female. This mating occurred in a Plexiglas box separate from, but similar to, the experimental chamber.
If the male readily mated, he was moved to the next phase of his adaptation. First the male's collar was attached to an 11 cm chain with a small swivel hook on either end. One end of the chain was attached to the collar and the other end was attached to a hook at the upper right hand corner of the Plexiglas training box. The male was left alone in the apparatus for ∼ 5 min while he became accustomed to being tethered. Thereafter, a nonexperimental, receptive female was introduced into the apparatus, and the male was allowed to mate. The introduction of the female calmed the male but was not always accompanied by mating. If mating did not occur within 15 min, the tether was removed and the male was allowed to mate until he ejaculated. This tethering process continued until the male (tethered to the corner hook) readily initiated mating upon introduction of the female. Mating was allowed to continue until the male ejaculated. At least two such successive ejaculation days while the male was tethered were required before he was moved to the actual experimental chamber for one additional day of adaptation with ejaculation.
Procedural development
Seven ovariectomized rats were used for the development of the procedures. During conditioning, the rats were always hormonally primed with estradiol benzoate and progesterone. After they were trained to produce the nose poke response, we initiated training with a 15-s delay between the first nose poke and the nose poke that would open the door to the male. After conditioning as described above, rats were given a 2-week washout period. The following week, the same rats were hormonally primed with 10 μg estradiol benzoate only and were tested. One week later, a pilot examination of the effects of fluoxetine was conducted in rats that were hormonally primed with estradiol benzoate and progesterone. Two rats received 15 mg/kg fluoxetine; two rats received 10 mg/kg fluoxetine; and three rats received 5 mg/kg fluoxetine. A before-and-after paradigm was used, with females given 5 min test and then injected with fluoxetine. Testing occurred 30 min after the fluoxetine injection.
Effects of 5 mg/kg fluoxetine Eleven rats were used in this experiment. After females reached a stable level of performance during testing with a 15-s delay, a within-subjects design was used, with eight females examined before and after fluoxetine treatment. On the day of testing, females that were hormonally primed with 10 μg estradiol benzoate, followed 48 h later by priming with 500 μg progesterone, were tested for 5 min in the chamber, and their behaviors were recorded. After the 5-min test, eight females were removed and injected with 5 mg/kg fluoxetine. After 30 min, the females were returned to the chamber for an additional 5-min test. Data were compared before and after fluoxetine treatment on the following parameters: (i) number of nose pokes per 15-s episode; (ii) number of episodes; (iii) total number of nose pokes per 5-min interval; and (iv) time to enter the male's compartment after the door opened. If the female failed to open the door or enter the male's chamber, she was given a score of 300 s for each parameter.
Three animals were tested before and after a water injection to determine whether the injection alone affected the behavior. Females were tested for 5 min and then injected with deionized water. After 30 min, the females were returned to the chamber for a 5-min posttest, as for the fluoxetine treatment.
Effects of ejaculation during conditioning of rats used for the 5 mg/kg fluoxetine study Data during training sessions were evaluated for (i) the number of nose pokes performed to open the door, (ii) the time to initiate a nose poke episode, and (iii) the latency to cross to the male's chamber after the door opened. Although not originally planned in the experimental design, we examined these parameters in the final training sessions to compare the females' behavior before and after ejaculation. One rat received two ejaculations in the same session, and both were included in the analysis. Data were compared between the episodes before and after ejaculation.
Drugs and materials
Estradiol benzoate, progesterone, fluoxetine [methyl [3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl]ammonium chloride], and sesame seed oil were purchased from Sigma-Aldrich Chemical Co. (St. Louis, Missouri, USA). Isoflurane (AErrane) was purchased from Butler Schein Animal Health (Dublin, Ohio, USA). Other supplies were obtained from Fisher Scientific (Houston, Texas, USA).
Statistical analysis
A session was defined as a day of testing. In most cases, the following parameters were assessed within a session: Parametric data were analyzed using the t-test for matched pairs (before and after fluoxetine or before and after water). Because most fluoxetine-treated females did not leave their chambers during the 5-min interval, data on the time to leave the chamber after the door had been opened were compared using nonparametric Wilcoxon's procedures (Zar, 2010) .
Results

Procedure development
After the initial shaping, as indicated by the rapidity in opening the guillotine door, the rats varied in the degree to which they had successfully acquired the task. Two rats rapidly opened the door, whereas five rats were slower in doing so (Fig. 2) . During additional sessions, the behavior of all rats improved, such that they opened the door within approximately the first minute after placement into the chamber. By these final sessions, the females made a majority of their nose pokes on the active rather than the inactive nose poke hole. The average number nose pokes per session in the inactive hole was 0.66 0.4 (range of 0-2).
After training, the rats were given a 2-week rest period to eliminate hormones before testing with just 10 μg estradiol benzoate priming. Because training of the females was on a staggered schedule, two females were still undergoing conditioning during this 2-week washout period; thus, only five rats were included in the comparison. When compared with rats primed with estradiol benzoate and progesterone (Fig. 3) , rats primed with only estradiol benzoate took a significantly longer time to open the door (t = 2.84, P ≤ 0.025) and were slower to enter the male's chamber. However, because of the performance variability, the differences in the time to cross to the male's chamber approached, but did not reach, statistical significance (t = 2.09, P ≤ 0.07).
The following week, after all the rats had completed conditioning, the rats were examined before and after injection with 5 mg/kg (n = 3), 10 mg/kg (n = 2), or 15 mg/kg (n = 2) fluoxetine ( Fig. 4) . When the data from the 10 and 15 mg/kg fluoxetine doses were combined and compared with the 5 mg/kg dose, there was a clear dose-dependent effect of treatment on the time to open the door (t = 7.19, P ≤ 0.001) but not on the time to cross. On the basis of this pilot study, 5 mg/kg fluoxetine was selected for further study.
Effects of 5 mg/kg fluoxetine Since females varied in the number of sessions required to reach a stable level of performance, an additional conditioning trial was included in the shaping phase to assure that behavior during the 15-s delay trials was successful (Table 1) . Thereafter, eight rats were tested before and after administration of 5 mg/kg fluoxetine and three rats were tested before and after a water injection.
As the behavior of Fischer females has been shown to be affected by an intraperitoneal injection (Uphouse et al., 2005) , an independent group of rats was used for testing with the water injection.
Fluoxetine reduced sexual motivation in female rats, as assessed by the number of nose pokes per episode, the number of nose poke episodes, the total number of nose pokes (nose pokes/episode × number of episodes), and by the latency to cross to the male's chamber ( Fig. 5 and Table 2 ). The average number of nose pokes per episode that females made during the 15-s delay interval was reduced by approximately 50% after fluoxetine treatment. As the number of episodes was reduced, the total number of nose pokes during the 5-min test interval was also reduced by fluoxetine. As expected from earlier studies showing effects of fluoxetine on time spent with a sexually active male in a pacing paradigm (Adams et al., 2012) , fluoxetine also increased the females' latency to enter the male's chamber even after the door had been opened. Six of the eight females failed to ever enter the male's chamber after fluoxetine administration. Although there was no obvious evidence that females treated with the low dose of 5 mg/kg fluoxetine had any motor disturbance, we directly tested this possibility by manually moving the females to the male's chamber at the end of the 5-min test. Every female rapidly (within 5 s) left the male's chamber; hence, we are confident that the females' lack of entry into the male's chamber was not a result of any motor disturbance.
Data for rats injected with water are shown in Table 3 . Unlike fluoxetine treatment, the females' behaviors were not changed by water injection (all P's > 0.05).
In a final analysis of the training data, we examined the females' behavior during the final training sessions for the episodes before and after an ejaculation had taken place. Data obtained before and after ejaculation are shown in Table 4 . After the male had ejaculated, the female took longer to initiate the next episode of nose pokes and exhibited a fewer number of nose pokes during the 15-s delay interval. The most robust change was in the females' latency to initiate a new nose poke episode.
Discussion
To our knowledge, this is the first report of an attempt to quantitatively evaluate antidepressant-induced decrements in female rat sexual motivation with an operant model. Attempts to demonstrate antidepressant-induced decrements in female sexual motivation in animal models have been surprisingly disappointing. The current findings allow the suggestion that the nose poke paradigm initially described by Cummings and Becker (2012) offers a promising approach for the study of antidepressant-emergent sexual dysfunction.
During the development of the paradigm, variability in female performance was initially large, but after further training, all females successfully performed the nose poke response to open the door to the male. We first compared rats treated with estradiol benzoate and progesterone with those treated only with estradiol benzoate. This comparison was important in validating the operant model in the Fischer inbred strain. A dose of 10 μg estradiol benzoate administered alone leads to high levels of lordosis behavior in Fischer females. However, proceptivity (generally viewed as evidence of a female's motivation to mate) does not typically occur without the progesterone priming. As rats administered only estradiol benzoate evidenced lower responses indicative of sexual motivation (e.g. time to open the door and time to enter the male's chamber after the door had been opened), the paradigm was able to successfully differentiate the two types of hormonal priming. This differentiation is Data are grouped to show the rats that reached the criterion during initial shaping (n = 2, high) and those that required additional experience (n = 5, low). On the basis of these results, additional shaping trials were introduced into the methodology. 
Time to cross
Preliminary dose-response for fluoxetine. Data are expressed as mean SE for time to open the door and time to cross to the male's chamber before and after treatment with 5 mg/kg (n = 3), 10 mg/kg (n = 2), or 15 mg/kg (n = 2) fluoxetine. If an animal failed to open the door, the female was given a maximum score of 300 s. Similarly, if the female opened the door but did not cross to the male's chamber, she was given a score of 300 s. *Significant dose-dependent effect for time to open the door. consistent with the hormonal conditions required for proceptivity in Fischer inbred rats.
When different doses of fluoxetine were examined in a preliminary dose-response analysis, motivational behaviors were reduced by all doses of fluoxetine. From these preliminary data, we chose 5 mg/kg fluoxetine as the dose with which to expand these preliminary studies.
In general, the current evidence with fluoxetine is consistent with studies in which fluoxetine has been shown to reduce female rat lordosis behavior and proceptivity (Sarkar et al., 2008; Miryala et al., 2011; Ventura-Aquino and Fernandez-Guasti, 2013) . The findings are also consistent with prior studies in which fluoxetine was reported to reduce a female's exit from a compartment to interact with a sexually active male (Adams et al., 2012) and with one report of a decrease in preference for the male in the partner-preference paradigm (Matuszczyk et al., 1998) . However, in a more recent study, when fluoxetine was used in the partner-preference model of sexual motivation, no effect of fluoxetine was seen (Sarkar et al., 2008) . In fact, in the majority of studies with SSRI antidepressants, there has been little evidence that the more traditional animal models of sexual motivation discriminate between antidepressant-treated and control rats (Snoeren et al., 2011a (Snoeren et al., , 2011b Kaspersen and Agmo, 2012) . For example, in our laboratory, we used the partner-preference paradigm to examine hormonally primed, ovariectomized Fischer females administered a single dose or multiple doses of fluoxetine (Sarkar et al., 2008) . The female's preference for spending time near the male incentive was not reduced by fluoxetine even under conditions in which the antidepressant significantly reduced lordosis behavior. Thus, the current paradigm may be more suitable for detection of SSRIinduced sexual motivational deficits than the partnerpreference paradigm.
There may, therefore, be advantages to the current paradigm over the more commonly used animal models of female rat sexual motivation. Most importantly, the paradigm allows a robust differentiation between fluoxetine-treated and control rats at a relatively low dose of fluoxetine that has been shown to have only minor effects on locomotor or consummatory (e.g. lordosis) behavior in Fischer rats (Miryala et al., 2011) . In addition, the paradigm offers the opportunity to conduct trial-bytrial behavioral assessment of the females' sexual motivation, such that training effects could also be examined.
Although not originally an objective of the current project, we quickly observed that the females' behavior in training after ejaculation was different from that before 
Number of episodes
Effects of 5 mg/kg fluoxetine. Data are expressed as mean SE for the number of nose pokes/episode and the number of episodes before and after treatment with 5 mg/kg fluoxetine (n = 8). *Significant difference before and after fluoxetine (P < 0.02). ejaculation. When we examined behavioral parameters before and after ejaculation, the number of nose pokes and the time to initiate a nose poke declined after ejaculation. Such an apparent ejaculation-induced decline in the females' sexual motivation is consistent with studies using the pacing paradigm, in which females can control entry and exit from the male (Erskine, 1989; Paredes and Vazquez, 1999) . This could also be an excellent paradigm for studying the effects of longer-term antidepressant treatment. Moreover, if sufficient time were allowed for drug metabolism, the current paradigm could allow the same female to be subjected to multiple pharmaceutical treatments and/or a dose-response effect within type of treatment. After the female acquired a stable response rate, the female's behavior remained relatively consistent even with as much as 2 weeks between testing.
Limitations of the paradigm include the long-term training that is required for females to acquire the nose poke response and to associate it with the ability to access the male. However, this limitation may be offset by the potential for repeated testing within the same animal.
In summary, the operant conditioning paradigm shows considerable promise as a tool for studying female sexual motivation in general and SSRI-induced sexual dysfunction in particular. Despite their potential for producing sexual dysfunction in humans, an SSRI-induced reduction in female sexual motivation has been difficult to demonstrate in animal models. Therefore, the robust effect of fluoxetine in the current paradigm is unique. Future studies will be required to determine whether these robust outcomes can be extended to other SSRIs, such as citalopram/paroxetine, and whether the paradigm is equally effective for other rat strains. In addition, although emphasis in the current paper was on female sexual motivation, it has not escaped our attention that the paradigm could also be useful for studying male sexual dysfunction.
